Hundreds of new priority anti-cancer drug targets, and biomarkers of which cases those drugs might work best, have been identified in a new study, offering a panoramic view of the genetic dependencies ...

A new, systematic analysis of cancer cells identifies 370 candidate priority drug targets across 27 cancer types, including breast, lung and ovarian cancers. By looking at multiple layers of ...

Scientists who conducted a new, systematic analysis of cancer cells report the identification of 370 candidate priority drug targets across 27 cancer types, including breast, lung, and ovarian cancers ...

Scientists from the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and Harvard and Columbia University have ...

The most comprehensive analysis of gene dependencies in cancer cells to date has identified 370 “highly enriched” drug targets in defined molecular backgrounds. This latest iteration of the Cancer ...

With the help of machine learning, scientists have identified a plethora of previously-unidentified drug targets for breast cancer, cervical cancer, glioblastoma and more. In a study published Jan. 11 ...

CRISPR/Cas9 gene editing has made possible a multitude of biomedical experiments including studies that systematically turn off genes in cancer cells to look for ones that the cancer cells heavily ...

Cancer genome alterations that cause cancer cells to grow also confer vulnerabilities, which normal cells lack. The challenge is that, for the majority of cancers, we do not understand the ...

Researchers have newly identified a universal, essential biomarker for the childhood cancer neuroblastoma – and a potential new target for treatment. Neuroblastoma accounts for 15% of all pediatric ...